Related Experiment Video
Updated: Nov 11, 2025

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
GABA transaminase deficiency. Case report and literature review
Amira Oshi1, Abdullah Alfaifi1, Mohammed Z Seidahmed1
1Department of Pediatrics Security Forces Hospital Riyadh Saudi Arabia.
Insights
GABA transaminase deficiency, a rare neurometabolic disorder, can cause early-onset epileptic encephalopathies. Early diagnosis is crucial for families, enabling genetic counseling and reproductive options like pre-implantation genetic diagnosis.
Area of Science:
- Neurology
- Metabolic Disorders
- Genetics
Background:
- Early-onset epileptic encephalopathies represent a diagnostic challenge.
- Neurometabolic disorders are often rare and difficult to identify.
- GABA transaminase deficiency is a specific, treatable cause of these conditions.
Observation:
- A case study highlighted the post-mortem diagnosis of GABA transaminase deficiency in an infant.
- The diagnosis occurred within a family with a history of unexplained infant neurological issues.
- This rare neurometabolic disorder presented as severe epilepsy.
Findings:
- GABA transaminase deficiency was confirmed as the cause of the infant's neurological condition.
- The diagnosis was established through post-mortem examination.
- Genetic analysis confirmed the specific deficiency.
Implications:
- Increased vigilance for GABA transaminase deficiency can lead to earlier diagnoses in affected infants.
- Genetic counseling is vital for families with rare neurometabolic disorders.
- Reproductive options, such as pre-implantation genetic diagnosis, can be offered to at-risk families.
Abstract:
GABA transaminase deficiency should be considered in the differential diagnosis of early onset epileptic encephalopathies. This case was diagnosed post-mortem, but increased vigilance to this will allow for earlier diagnoses in other infants and families. This is a case study which involved diagnosis of a rare neurometabolic disorder in one of the babies in the family and eventual genetic counselling of the family. The family has been offered pre-implantation genetic diagnosis for future pregnancies. This case reporting has been approved by the hospital research and ethical committee.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Inborn Errors of Metabolism
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

